BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31381408)

  • 21. Lower Prices and Greater Patient Access - Lessons from Germany's Drug-Purchasing Structure.
    Robinson JC
    N Engl J Med; 2020 Jun; 382(23):2177-2179. PubMed ID: 32492300
    [No Abstract]   [Full Text] [Related]  

  • 22. New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines.
    Suleman F; Low M; Moon S; Morgan SG
    BMJ; 2020 Jan; 368():l4408. PubMed ID: 31932324
    [No Abstract]   [Full Text] [Related]  

  • 23. The challenge of paying for cost-effective cures.
    Zettler PJ; Fuse Brown EC
    Am J Manag Care; 2017 Jan; 23(1):62-64. PubMed ID: 28141931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. State prescription drug price Web sites: how useful to consumers?
    Tu HT; Corey CG
    Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical Price and Spending Controls in France: Lessons for the United States.
    Rodwin MA
    Int J Health Serv; 2020 Apr; 50(2):156-165. PubMed ID: 32000577
    [No Abstract]   [Full Text] [Related]  

  • 26. Reducing Hospital Pharmacy Spend After Pharmaceutical Price Increases-Don't Get Mad, Get Lean.
    Keren R; Hadley SE; Patel NS
    JAMA Pediatr; 2018 Nov; 172(11):1005-1006. PubMed ID: 30264131
    [No Abstract]   [Full Text] [Related]  

  • 27. Pandora's Prescription: The Pharmaceutical Pricing
    Pederson T
    FASEB J; 2017 Nov; 31(11):4661-4662. PubMed ID: 29093000
    [No Abstract]   [Full Text] [Related]  

  • 28. International drug price comparisons: quality assessment.
    Machado M; O'Brodovich R; Krahn M; Einarson TR
    Rev Panam Salud Publica; 2011 Jan; 29(1):46-51. PubMed ID: 21390419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical Pricing in Germany: How Is Value Determined within the Scope of AMNOG?
    Lauenroth VD; Stargardt T
    Value Health; 2017; 20(7):927-935. PubMed ID: 28712622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey: Millions of People in the US Forgo Medications to Reduce Costs.
    Harris E
    JAMA; 2023 Jul; 330(1):13. PubMed ID: 37314834
    [No Abstract]   [Full Text] [Related]  

  • 31. Prices and availability of pharmaceuticals: evidence from nine countries.
    Danzon PM; Furukawa MF
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-521-36. PubMed ID: 15506157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of modern economic methods for the rational choice of drugs].
    Khveshchuk PF; Rudakova AV; Galin AL
    Voen Med Zh; 1999 Aug; 320(8):54-9. PubMed ID: 10524003
    [No Abstract]   [Full Text] [Related]  

  • 33. Specialty Drugs - A Distinctly American Phenomenon.
    Naci H; Kesselheim AS
    N Engl J Med; 2020 Jun; 382(23):2179-2181. PubMed ID: 32492301
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of regulation on drug launch and pricing in interdependent markets.
    Danzon PM; Epstein AJ
    Adv Health Econ Health Serv Res; 2012; 23():35-71. PubMed ID: 23156660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [How much do medicines that are thrown away cost?].
    Salgado Ramos J; Maeso Corroto R; Machín Hamalainen S; Tapias Merino E
    Aten Primaria; 2004; 34(3):152-3. PubMed ID: 15274906
    [No Abstract]   [Full Text] [Related]  

  • 36. Can ICER bring cost-effectiveness to drug prices?
    Butcher L
    Manag Care; 2019 Jun; 28(6):30-33. PubMed ID: 31188097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The burden of cost--admission versus discharge medications.
    Akintola A; Yousset M; Oh S; Byrne D; Liston R
    Ir Med J; 2014 Jun; 107(6):187. PubMed ID: 24988841
    [No Abstract]   [Full Text] [Related]  

  • 38. Availability and affordability of priority life-saving medicines for under-five children in health facilities of Tigray region, northern Ethiopia.
    Abrha S; Tadesse E; Atey TM; Molla F; Melkam W; Masresha B; Gashaw S; Wondimu A
    BMC Pregnancy Childbirth; 2018 Nov; 18(1):464. PubMed ID: 30497441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in Prices of Popular Brand-Name Prescription Drugs in the United States.
    Wineinger NE; Zhang Y; Topol EJ
    JAMA Netw Open; 2019 May; 2(5):e194791. PubMed ID: 31150077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early benefit assessment for pharmaceuticals in Germany: lessons for policymakers.
    Schlette S; Hess R
    Issue Brief (Commonw Fund); 2013 Oct; 29():1-9. PubMed ID: 24171232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.